CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −947 | $263.94 | $250K | 130,572 |
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −192 | $265.28 | $51K | 130,380 |
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,233 | $267.79 | $330K | 129,147 |
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −128 | $268.70 | $34K | 129,019 |
| 2026-08-03 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −334 | $267.99 | $90K | 170,073 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,182 | $267.99 | $317K | 101,791 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −160 | $259.98 | $42K | 101,631 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −70 | $261.03 | $18K | 101,561 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −676 | $263.86 | $178K | 100,885 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −80 | $265.27 | $21K | 100,805 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −296 | $267.08 | $79K | 100,509 |
| 2026-08-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −612 | $268.22 | $164K | 99,897 |
| 2026-08-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −317 | $267.99 | $85K | 52,115 |
| 2026-08-03 | Sheena Jonathan Director | Sale 10b5-1 | −109 | $267.99 | $29K | 245,614 |
| 2026-08-03 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −731 | $267.99 | $196K | 2,275,394 |
| 2026-07-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,863 | $249.38 | $465K | 52,432 |
| 2026-07-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −931 | $254.07 | $237K | 184,069 |
| 2026-07-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,204 | $254.07 | $306K | 132,429 |
| 2026-07-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,003 | $254.07 | $255K | 170,407 |
| 2026-07-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,580 | $254.07 | $910K | 102,973 |
Page 11 of 39 · 767 trades